Ketoprofen Extended-Release Capsules and Mogamulizumab-kpkc Intravenous
Determining the interaction of Ketoprofen Extended-Release Capsules and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ketoprofen
Brand name: Oruvail, Orudis, Actron, Orudis KT
Synonyms: Ketoprofen
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ketoprofen Extended-Release Capsules-Molindone
- Ketoprofen Extended-Release Capsules-Mometasone (Oral Inhalation)
- Ketoprofen Extended-Release Capsules-Mometasone and Formoterol
- Ketoprofen Extended-Release Capsules-Mometasone and formoterol Inhalation
- Ketoprofen Extended-Release Capsules-Mometasone Cream
- Ketoprofen Extended-Release Capsules-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Ketorolac
- Mogamulizumab-kpkc Intravenous-Ketorolac (Systemic)
- Mogamulizumab-kpkc Intravenous-Ketorolac Eye Drops (Multi-Dose Containers)
- Mogamulizumab-kpkc Intravenous-Ketorolac Eye Drops (Single-Dose Containers)
- Mogamulizumab-kpkc Intravenous-Ketorolac Injection
- Mogamulizumab-kpkc Intravenous-Ketorolac nasal